“It is great to see the progression in the installation of the Isotope Production System, which provides us with an additional reliable source to increase the scalability of our n.c.a. Lutetium-177 production for global supply as well as the further clinical development of our broad pipeline,” commented Steffen Schuster, CEO of ITM. “We look forward to leveraging our long-term partnership with Bruce Power to deliver Targeted Radionuclide Therapy to cancer patients worldwide.”
Bruce Power’s collaboration with Saugeen Ojibway Nation (SON) will see the partners jointly marketing new isotopes in support of the global fight against cancer while also working together in creating new economic opportunities within the SON territory by establishing new isotope infrastructure.
Carestream Health is a leading provider of quality X-ray systems and detectors that are designed to maximize diagnostic confidence, workflow and patient satisfaction. Follow the link above to see our complete portfolio of digital radiography solutions.
“It’s very exciting times for SON as we move forward to the next phase of the Isotope project with Bruce Power,” said Chief Lester Anoquot, Chippewas of Saugeen First Nation. “Many members of our community have been impacted by cancer in some way. We are proud to play a leadership role in the global fight against cancer, while building economic opportunities in our community.”
The partnership, which includes an equity stake and revenue-sharing model for SON, is named Gamzook’aamin aakoziwin, which means ‘We are Teaming up on the Sickness’ in the traditional Anishinaabe language.
“The Gamzook’aamin aakoziwin project will positively impact people worldwide, well beyond the borders of our community,” said former Chief Greg Nadjiwon of Chippewas of Nawash Unceded First Nation. “This project is a groundbreaking development in the fight against cancer, and represents a positive step forward for the global medical community.”
For more information on Gamzook’aamin aakoziwin visit www.fightingcancertogether.ca.
The approved project will expand Bruce Power’s established isotope production, and will solidify the company as an integral producer of critical medical isotopes increasingly being used in innovative nuclear medicine applications.
“Ontario continues to position itself as a world leader in the production of life-saving medical isotopes,” said Energy Minister Todd Smith. “The innovation of companies like Bruce Power and its partners is critical to ensuring increased capacity of isotope production to improve global access to these essential tools in the fight against cancer. Today’s announcement is a big step forward in furthering the goal of long-term, sustainable, and flexible production of medical isotopes at the Bruce Power site.”